Class Labeling Issues Could Speed Adoption Of New Highlights Format
Executive Summary
Manufacturers may have an incentive to reformat labeling of their products sooner than would otherwise be required to prevent competing firms from setting the standard for the new Highlights section, FDA Office of Medical Policy Director Robert Temple suggested
You may also be interested in...
FDA Unhappy With New Label Format Submissions; Requests Clarity, Brevity
Submissions to FDA in the new labeling format have thus far failed to meet agency expectations with regard to content requirements
FDA Unhappy With New Label Format Submissions; Requests Clarity, Brevity
Submissions to FDA in the new labeling format have thus far failed to meet agency expectations with regard to content requirements
New Drug Labeling Format Encourages Physician-Patient Interaction
FDA's final labeling rule creates several new sections designed to facilitate physicians' drug prescribing practices